NEW YORK - The emergence of the omicron variant has renewed fears of the novel coronavirus developing mutations that would allow it to evade existing vaccines, but the companies Pfizer and BioNTech ...

The CHMP’s recommendation will be reviewed by the European Commission (EC), which is expected to make its final decision soon. Pfizer and BioNTech have already initiated manufacturing of the ...

A third dose of the Pfizer/BioNTech COVID-19 vaccine can "strongly" boost protection against the delta variant -- beyond the protection afforded by the standard two doses, suggests new data released ...

The World Health Organization and the Centers for Disease Control and Prevention have both designated beta as a “variant of ...

NEW YORK, N.Y. — Pfizer announced Wednesday that data shows a third dose of its COVID-19 vaccine can “strongly” boost protection against the highly transmissible delta variant. The pharmaceutical and ...

A Pfizer-BioNTech Covid-19 booster shot appears to provide strong protection against the omicron variant, while the initial two-dose vaccine may be insufficient to prevent infection, the companies ...

From oncology to obesity, Pfizer bets big on India for its next growth wave Pfizer is prioritizing India for future growth.

PHILADELPHIA -- To help fend off another wave of Covid-19, people will need a fourth dose of vaccine, Pfizer CEO Albert Bourla said Sunday. "Many variants are coming, and Omicron was the first one ...

Newly released data from Pfizer/BioNTech’s ongoing study of their COVID-19 vaccine suggests it is effective at preventing serious symptoms and death at least six months after vaccination. The ...